U
ACER

UBS’s Acer Therapeutics Inc ACER Stock Holding History

UBS’s Portfolio ACER Stock Details ACER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$23K Buy
283
+257
+988% +$30.5K ﹤0.01% 7834
2014
Q2 		$4K Sell
26
-87
-77% -$11.5K ﹤0.01% 9711
2014
Q1 		$18K Buy
113
+91
+414% +$13.8K ﹤0.01% 8254
2013
Q4 		$3K Sell
22
-19
-46% -$3.09K ﹤0.01% 9902
2013
Q3 		$7K Sell
41
-24
-37% -$3.21K ﹤0.01% 9160
2013
Q2 		$9K Buy
+65
New +$9.49K ﹤0.01% 8759

Other funds holding ACER

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
SKK
Shepherd Kaplan Krochuk Boston, Massachusetts $119M AUM 8.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
MC
Moors & Cabot Boston, Massachusetts $2.34B AUM 30.42% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

UBS's ACER Position: Q3 2014 in Review

UBS increased its Acer Therapeutics Inc (ACER) stake by 988% in Q3 2014, buying an estimated $30.5K and bringing the position to 283 shares worth $23K. The position accounts for ﹤0.01% of the portfolio, ranked #7834.

UBS first reported a position in ACER in Q2 2013 and has held it in 6 quarters since. 18 funds tracked by Wall St. Rank hold ACER as of Q3 2014.

  • UBS held 283 shares of Acer Therapeutics Inc worth $23K as of Q3 2014.
  • UBS bought 257 Acer Therapeutics Inc shares in Q3 2014, an estimated $30.5K.
  • Acer Therapeutics Inc made up ﹤0.01% of UBS's portfolio in Q3 2014, its #7834 holding.
  • UBS first reported a position in Acer Therapeutics Inc in Q2 2013 and has held it in 6 quarters since.
  • 18 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.